The decision means that Medicare beneficiaries can now receive coverage for the EST, which provides a non-endoscopic, minimally invasive method to monitor esophageal inflammation. The test enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback